Impact of CHA2DS2-VASc and HAS-BLED SCORES on oral anticoagulant use and outcomes in patients with atrial fibrillation and concomitant heart failure: an analysis of 22,055 patients from the SwedeHF
26 August 2017 (00:00 - 00:00)
Organised by:
About the speaker

Karolinska Institute, Stockholm (Sweden)
3 More presentations in this session

Doctor L. Vissers (Utrecht, NL)

Doctor M. Schmidt (Aarhus, DK)
Access the full session
The Event
ESC Congress 2017
26 August - 30 August 2017

